Vivan Therapeutics

Portfolio company short bio
Vivan Therapeutics is a London based biotechnology company offering cancer patients worldwide access to the most advanced personalised cancer therapeutics based on technology pioneered at The Mount Sinai School of Medicine, New York.
Portfolio Company Info

We identify personalised cancer treatments for patients based on their tumour genetics. For each patient, we build a genetically matched fruit fly model of the tumour, which is used for large-scale drug screening to find novel and effective drug combinations. This platform can treat even difficult cancers with combinations of approved drugs. Nearly all combinations incorporate non-cancer drugs, making them less toxic and more affordable. Using our proprietary screening data, we are building a powerful AI-driven digital health tool, which can predict effective treatment options rapidly. Our in vivo, high throughput drug screening platform is also used to power biopharma discovery and development.

Card info


Founder/CEO name: Laura Towart (LinkedIn)

Founded: 2018
Location: London, United Kingdom
Sector: Biotechnology, HealthTech - personalized medicine;
Total amount raised (mln EUR): 3.60
Employees range: 2-10

Request a contact